( March 10, 2025, 4:52 PM EDT) -- FORT WORTH, Texas — A Texas federal judge refused to grant a preliminary injunction and stay on the U.S. Food and Drug Administration’s decision to remove an FDA-approved drug for diabetes and weight loss from the agency’s drug shortage list, finding in an order unsealed March 7 that companies representing the interests of drug compounders failed to show a likelihood of “success on the merits of their claims, which is the most important (and usually decisive) factor.”...